TELA Bio (NASDAQ: TELA) director Thomas Paul files initial Form 3 ownership

Rhea-AI Filing Summary

TELA Bio, Inc. director Thomas Paul filed an initial Form 3, which is a required statement of beneficial ownership for company insiders. This filing lists him as a director but does not report any specific stock transactions or derivative positions in the provided data.

Key Figures

Buy transactions: 0 Sell transactions: 0 Net buy/sell shares: 0 shares +1 more

4 metrics

Buy transactions 0 Form 3 transaction summary buyCount

Sell transactions 0 Form 3 transaction summary sellCount

Net buy/sell shares 0 shares Form 3 transaction summary netBuySellShares

Derivative transactions 0 Form 3 derivativeTransactionCount

Key Terms

Form 3, beneficial ownership, reporting person

3 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3)"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership regulatory

"initial statement of beneficial ownership for company insiders"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

reporting person regulatory

""reportingPersons": [ { "name": "THOMAS PAUL""

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Available on EDGAR 06/11/2026 - 06:07 PM Accepted by SEC EDGAR 06/11/2026 - 06:06 PM Learn about SEC filing dates

FAQ

What does Thomas Paul’s Form 3 filing for TELA (TELA) indicate?

The Form 3 shows that Thomas Paul is a director of TELA Bio, Inc. It is an initial statement of beneficial ownership and, in the provided data, does not list any specific share holdings or recent transactions.

Are there any share purchases or sales reported in this TELA (TELA) Form 3?

No transactions are reported in this Form 3 excerpt. The transaction summary shows zero buy, sell, acquire, dispose, or exercise entries, indicating no trades or derivative exercises are disclosed here for Thomas Paul.

Does Thomas Paul hold derivatives or options in TELA Bio (TELA) in this filing?

The provided data shows an empty derivativeSummary and a derivativeTransactionCount of zero. This means no options, warrants, or other derivative securities are disclosed for Thomas Paul in this particular Form 3 excerpt.

Why is a Form 3 important for TELA Bio (TELA) investors?

Form 3 establishes who is an insider, such as directors, officers, or large shareholders. Knowing insider status helps investors track future Forms 4 and 5, which will disclose any later trades or changes in beneficial ownership by those insiders.

Does the Form 3 for TELA (TELA) mention any Rule 10b5-1 trading plan?

The provided Form 3 data, including footnotes, does not reference a Rule 10b5-1 trading plan. Since no transactions are listed, there is no indication here of pre-planned trading activity by Thomas Paul.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

THOMAS PAUL

(Last) (First) (Middle)

C/O TELA BIO, INC.

1 GREAT VALLEY PARKWAY, SUITE 24

(Street)

MALVERN PENNSYLVANIA 19355

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/09/2026

3. Issuer Name and Ticker or Trading Symbol
TELA Bio, Inc. [ TELA ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Megan Smeykal, Attorney-in-Fact	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)